Sanofi CEO believes company poised for growth from new drugs
Sanofi's chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a ...
Immunic’s MS Drug Candidate Shows Promising Future: A Comprehensive Buy Rating Justification
B.Riley Financial analyst William Wood has reiterated their bullish stance on IMUX stock, giving a Buy rating on September 16. William Wood ...
AB Science Provides An Update On The Development Of Masitinib In Progressive Forms Of Multiple Sclerosis Post ECTRIMS 2024
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE DEVELOPMENT OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE ...
pharmaphorum8h
UCB, Biogen lupus drug scores in phase 3 trial
As usual, a second trial will be needed before UCB and Biogen can file dapirolizumab pegol with regulators. It will be called ...
Systemic sclerosis research finds protein TLR8 influences the production of disease-related cytokines
Systemic sclerosis is an autoimmune disease that primarily causes inflammation of the skin, as well as internal organs such ...
Multiple sclerosis symptoms at onset linked to long-term disability
Multiple sclerosis (MS) research has uncovered a potential link between certain initial symptoms and long-term disability ...
News Medical1h
Study links initial symptoms to long-term disability in multiple sclerosis
In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes.
Too Old to Operate8h
Evaluating the Specificity of Diagnostic Criteria for Mast Cell Activation Syndrome
The following is a summary of “Clustering of clinical symptoms using large language models reveals low diagnostic specificity of proposed alternatives to consensus mast cell activation syndrome ...